fda semaglutide shortage resolved february 2025 announcement 📢 has determined the of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the GLP-1 Drugs: FDA Removes Semaglutide

Consider your activity level: If you have any significant physical activities planned, like a long hike or a vital sports game, you should avoid taking your dose early if it falls on that day

Not everyone does, but labs can be helpful especially if fatigue or suspected deficiencies are part of the story

Both semaglutide and liraglutide have also shown positive metabolic effects, such as improved insulin sensitivity, lowered glucose production in the liver, and increased thermogenesis

Your provider needs to consider this when prescribing other treatments

Compounded versions are not FDA-approved and have not undergone clinical trials